$30.12
-0.98-3.15%
At close: -
$30.12
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Comments
Loading...
Veracyte Insider Trading Activity | NASDAQ:VCYT | Benzinga
Track the latest Veracyte insider trading activity. Stay informed on recent buys, sells, and market impact for Veracyte stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Veracyte Inc Insiders Doing?
At Veracyte Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 64.27K shares worth $2.52M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 5, 2025, Rebecca Chambers, the company's CHIEF FINANCIAL OFFICER sold 527 shares for $43.85 each.
- On March 6, 2025, Annie McGuire, the company's SVP, GENERAL COUNSEL sold 1.14K shares for $33.69 each.
- On March 6, 2025, Phillip Febbo, the company's CHIEF SCIENTIFIC & MED OFFICER sold 8.04K shares for $33.35 each.
Ownership Statistics for Veracyte Inc
Shares Outstanding
77.945M
Insider Shares Owned
1.498M
Insider Percentage Owned
1.92%
Institutional Shares Held
62.961M
Institutional Percentage Held
80.8%
| Mar 10, 2025 | John Leite | CHIEF COMMERCIAL OFFICER-CLIA | 28.83K | $31.66 | -$234.63K | GRANT | 40.37% | 100.25K | Mar 06 - Mar 07 | View |
| Mar 06, 2025 | Phillip Febbo | CHIEF SCIENTIFIC & MED OFFICER | -8.04K | $33.35 | -$268.01K | SELL | -8.87% | 82.54K | Mar 04 | View |
| Mar 06, 2025 | Marc Stapley | CHIEF EXECUTIVE OFFICER | -52.70K | $33.34 | -$1.76M | SELL | -16.43% | 268.04K | Mar 04 | View |
| Mar 06, 2025 | Annie McGuire | SVP, GENERAL COUNSEL | -1.14K | $33.69 | -$38.48K | SELL | -1.60% | 70.31K | Mar 04 | View |
| Mar 03, 2025 | John Leite | CHIEF COMMERCIAL OFFICER-CLIA | -2.39K | $34.37 | -$460.36K | SELL | -3.24% | 71.42K | Feb 27 - Mar 02 | View |
| Feb 05, 2025 | Rebecca Chambers | CHIEF FINANCIAL OFFICER | -527.00 | $43.85 | -$23.11K | SELL | -0.46% | 113.51K | Feb 03 | View |
| Jan 06, 2025 | KARIN EASTHAM | DIRECTOR | 0.00 | $22.79 | -$350.21K | SELL-OPTIONS | 0.00% | 18.50K | Jan 02 | View |
| Dec 17, 2024 | Marc Stapley | CHIEF EXECUTIVE OFFICER | -5.59K | $43.42 | -$242.74K | SELL | -1.79% | 307.35K | Dec 13 | View |
| Dec 06, 2024 | Phillip Febbo | CHIEF SCIENTIFIC & MED OFFICER | -3.93K | $44.09 | -$173.45K | SELL | -4.56% | 82.41K | Dec 04 | View |
| Dec 06, 2024 | Annie McGuire | SVP, GENERAL COUNSEL | -18.70K | $44.02 | -$823.18K | SELL | -20.42% | 72.87K | Dec 04 | View |
| Dec 04, 2024 | John Leite | CHIEF COMMERCIAL OFFICER-CLIA | -2.36K | $43.73 | -$103.38K | SELL | -3.10% | 73.81K | Dec 02 - Dec 03 | View |
| Dec 04, 2024 | Rebecca Chambers | CHIEF FINANCIAL OFFICER | -10.46K | $43.53 | -$455.45K | SELL | -8.40% | 114.04K | Dec 02 - Dec 03 | View |
| Dec 04, 2024 | Jonathan Wygant | VP, CHIEF ACCOUNTING OFFICER | -2.04K | $43.76 | -$89.41K | SELL | -4.83% | 40.27K | Dec 02 - Dec 03 | View |
| Nov 29, 2024 | Jonathan Wygant | VP, CHIEF ACCOUNTING OFFICER | -5.03K | $42.89 | -$215.83K | SELL | -10.63% | 42.31K | Nov 27 | View |
| Nov 21, 2024 | KARIN EASTHAM | DIRECTOR | -14.73K | $38.34 | -$564.77K | SELL | -44.33% | 18.50K | Nov 19 | View |
| Nov 14, 2024 | Rebecca Chambers | CHIEF FINANCIAL OFFICER | -15.28K | $38.34 | -$585.66K | SELL | -10.93% | 124.50K | Nov 12 | View |
| Nov 14, 2024 | ROBERT EPSTEIN | DIRECTOR | 0.00 | $23.18 | -$454.23K | SELL-OPTIONS | 0.00% | 44.60K | Nov 12 | View |
| Sep 23, 2024 | FA EVAN JONES | DIRECTOR | -5.17K | $35.23 | -$182.26K | SELL | -13.09% | 34.34K | Sep 19 | View |
| Sep 06, 2024 | John Leite | CHIEF COMMERCIAL OFFICER-CLIA | -5.48K | $29.78 | -$163.16K | SELL | -6.71% | 76.17K | Sep 04 | View |
| Aug 14, 2024 | FA EVAN JONES | DIRECTOR | -39.36K | $21.30 | -$1.45M | SELL | -88.38% | 5.17K | Aug 12 - Aug 13 | View |
| Aug 13, 2024 | FA EVAN JONES | DIRECTOR | -1.48K | $20.22 | -$50.27K | SELL | -4.35% | 32.46K | Aug 09 | View |
| Aug 09, 2024 | Jens Holstein | DIRECTOR | -5.00K | $29.00 | -$145.00K | SELL | -15.21% | 27.88K | Aug 07 | View |
| Aug 09, 2024 | FA EVAN JONES | DIRECTOR | -3.89K | $20.37 | -$142.25K | SELL | -4.62% | 80.35K | Aug 07 | View |
| Jul 18, 2024 | KARIN EASTHAM | DIRECTOR | -7.50K | $25.00 | -$187.50K | SELL | -18.41% | 33.23K | Jul 16 | View |
| Jul 18, 2024 | John Leite | CHIEF COMMERCIAL OFFICER-CLIA | -1.28K | $25.00 | -$31.93K | SELL | -1.52% | 82.97K | Jul 16 | View |
| Jul 18, 2024 | Jens Holstein | DIRECTOR | -5.00K | $24.50 | -$122.50K | SELL | -13.20% | 32.88K | Jul 16 | View |
| Jun 13, 2024 | KARIN EASTHAM | DIRECTOR | -3.87K | $20.59 | -$79.68K | SELL | -11.68% | 29.25K | Jun 11 | View |
| Jun 11, 2024 | Muna Bhanji | DIRECTOR | -3.87K | $20.32 | -$78.63K | SELL | -14.35% | 23.11K | Jun 10 | View |
| Jun 11, 2024 | KARIN EASTHAM | DIRECTOR | 0.00 | $15.69 | -$26.40K | SELL-OPTIONS | 0.00% | 33.13K | Jun 07 | View |
| May 30, 2024 | Muna Bhanji | DIRECTOR | -1.54K | $21.00 | -$32.32K | SELL | -5.40% | 26.98K | May 28 | View |
| Apr 02, 2024 | KARIN EASTHAM | DIRECTOR | 0.00 | $17.42 | -$84.63K | SELL-OPTIONS | 0.00% | 33.13K | Apr 01 | View |
| Mar 05, 2024 | FA EVAN JONES | DIRECTOR | 0.00 | $18.77 | -$111.70K | SELL-OPTIONS | 0.00% | 72.77K | Mar 01 | View |
| Jul 24, 2023 | FA EVAN JONES | DIRECTOR | -3.93K | $30.17 | -$118.49K | SELL | -10.05% | 35.17K | Jul 19 | View |
| Jul 19, 2023 | JOHN BISHOP | DIRECTOR | 0.00 | $18.31 | -$477.60K | SELL-OPTIONS | 0.00% | 33.13K | Jul 17 - Jul 18 | View |
| Jul 19, 2023 | FA EVAN JONES | DIRECTOR | -52.81K | $30.09 | -$1.59M | SELL | -57.99% | 38.26K | Jul 17 - Jul 18 | View |
| Jun 21, 2023 | Muna Bhanji | DIRECTOR | -5.89K | $26.44 | -$155.79K | SELL | -17.13% | 28.51K | Jun 16 | View |
| Jun 01, 2023 | Muna Bhanji | DIRECTOR | -1.54K | $25.91 | -$39.88K | SELL | -5.86% | 24.73K | May 30 | View |
| Apr 18, 2023 | Bonnie Anderson | DIRECTOR | 0.00 | $13.82 | -$558.62K | SELL-OPTIONS | 0.00% | 177.48K | Apr 14 | View |
| Mar 17, 2023 | KARIN EASTHAM | DIRECTOR | 0.00 | $17.45 | -$199.79K | SELL-OPTIONS | 0.00% | 23.45K | Mar 16 | View |
| Mar 16, 2023 | Bonnie Anderson | DIRECTOR | 0.00 | $14.19 | -$583.15K | SELL-OPTIONS | 0.00% | 177.48K | Mar 15 | View |
| Mar 02, 2023 | KARIN EASTHAM | DIRECTOR | 0.00 | $18.56 | -$128.80K | SELL-OPTIONS | 0.00% | 23.45K | Feb 28 | View |
| Jan 18, 2023 | Bonnie Anderson | DIRECTOR | 0.00 | $15.98 | -$705.10K | SELL-OPTIONS | 0.00% | 186.47K | Jan 17 | View |
| Jan 12, 2023 | Bonnie Anderson | DIRECTOR | 0.00 | $19.73 | -$682.23K | SELL-OPTIONS | 0.00% | 186.47K | Jan 11 | View |
| Dec 16, 2022 | FA EVAN JONES | DIRECTOR | -600.00 | $30.13 | -$18.08K | SELL | -0.50% | 119.84K | Dec 14 | View |
| Dec 15, 2022 | FA EVAN JONES | DIRECTOR | -1.67K | $30.71 | -$51.20K | SELL | -1.37% | 120.44K | Dec 13 | View |
| Dec 08, 2022 | Giulia Kennedy | CHIEF SCIENTIFIC & MED OFFICER | -1.02K | $27.03 | -$27.65K | SELL | -1.53% | 65.97K | Dec 06 | View |
| Dec 05, 2022 | Bonnie Anderson | EXECUTIVE CHAIRWOMAN | 0.00 | $19.66 | -$1.38M | SELL-OPTIONS | 0.00% | 188.52K | Dec 01 | View |
| Nov 15, 2022 | Giulia Kennedy | CHIEF SCIENTIFIC & MED OFFICER | 0.00 | $21.84 | -$30.00 | SELL-OPTIONS | 0.00% | 68.00K | Nov 11 | View |
| Nov 15, 2022 | FA EVAN JONES | DIRECTOR | -6.00K | $30.23 | -$181.36K | SELL | -4.68% | 122.10K | Nov 11 | View |
| Nov 08, 2022 | Giulia Kennedy | CHIEF SCIENTIFIC & MED OFFICER | -1.02K | $25.00 | -$25.57K | SELL | -1.48% | 68.00K | Nov 04 | View |
| Aug 09, 2022 | Bonnie Anderson | EXECUTIVE CHAIRWOMAN | -121.92K | $27.56 | -$3.36M | SELL | -40.45% | 179.47K | Aug 05 - Aug 08 | View |
| Aug 09, 2022 | Giulia Kennedy | CHIEF SCIENTIFIC & MED OFFICER | 9.68K | $17.19 | -$27.24K | SELL-OPTIONS | 16.04% | 70.03K | Aug 05 | View |
| Jun 16, 2022 | Jens Holstein | DIRECTOR | 6.01K | $16.27 | -$141.85K | GRANT | 56.07% | 16.73K | Jun 14 - Jun 16 | View |
| Jun 13, 2022 | Marc Stapley | CHIEF EXECUTIVE OFFICER | 60.00K | $16.33 | $980.09K | BUY | 60.14% | 159.76K | Jun 10 | View |
| Jun 10, 2022 | KEVIN GORDON | DIRECTOR | 0.00 | $12.95 | -$166.65K | SELL-OPTIONS | 0.00% | 8.72K | Jun 08 | View |
| Mar 07, 2022 | Giulia Kennedy | CHIEF SCIENTIFIC & MED OFFICER | 23.82K | $15.55 | -$551.43K | SELL-OPTIONS | 63.38% | 61.39K | Mar 03 - Mar 04 | View |
| Dec 20, 2021 | KARIN EASTHAM | DIRECTOR | 0.00 | $28.56 | -$164.40K | SELL-OPTIONS | 0.00% | 8.72K | Dec 17 | View |
| Dec 08, 2021 | Giulia Kennedy | CHIEF SCIENTIFIC & MED OFFICER | -1.08K | $27.84 | -$322.52K | SELL | -2.20% | 47.91K | Dec 06 - Dec 07 | View |
| Nov 03, 2021 | KARIN EASTHAM | DIRECTOR | -4.40K | $27.27 | -$119.97K | SELL | -33.54% | 8.72K | Nov 01 | View |
| Sep 21, 2021 | Bonnie Anderson | EXECUTIVE CHAIRWOMAN | -2.60K | $50.18 | -$130.48K | SELL | -0.91% | 282.02K | Sep 17 | View |
| Sep 14, 2021 | Bonnie Anderson | EXECUTIVE CHAIRWOMAN | -1.90K | $50.03 | -$95.05K | SELL | -0.66% | 284.62K | Sep 10 | View |
| Sep 09, 2021 | Giulia Kennedy | CHIEF SCIENTIFIC & MED OFFICER | -926.00 | $33.66 | -$470.05K | SELL | -1.82% | 50.05K | Sep 07 - Sep 08 | View |
| Aug 04, 2021 | KARIN EASTHAM | DIRECTOR | -4.40K | $43.91 | -$193.19K | SELL | -25.11% | 13.12K | Aug 02 | View |
| Jun 25, 2021 | Giulia Kennedy | CHIEF SCIENTIFIC & MED OFFICER | 0.00 | $32.22 | -$65.89K | SELL-OPTIONS | 0.00% | 51.89K | Jun 23 | View |
| Jun 08, 2021 | Giulia Kennedy | CHIEF SCIENTIFIC & MED OFFICER | -925.00 | $23.58 | -$212.38K | SELL | -1.75% | 51.89K | Jun 04 | View |
| Jun 04, 2021 | Jens Holstein | DIRECTOR | 2.00K | $35.19 | $70.39K | BUY | ∞ | 2.00K | Jun 03 | View |
| May 05, 2021 | KARIN EASTHAM | DIRECTOR | -4.43K | $48.27 | -$213.70K | SELL | -33.47% | 8.80K | May 03 | View |
| Mar 08, 2021 | Keith Kennedy as attorney-in-fact | CHIEF SCIENTIFIC & MED OFFICER | -21.05K | $34.08 | -$1.98M | SELL | -28.15% | 53.72K | Mar 04 | View |
| Feb 26, 2021 | KARIN EASTHAM | DIRECTOR | 0.00 | $32.35 | -$354.36K | SELL-OPTIONS | 0.00% | 0.00 | Feb 25 | View |
| Jan 15, 2021 | Bonnie Anderson | CHAIRMAN AND CEO | 0.00 | $28.33 | -$842.45K | SELL-OPTIONS | 0.00% | 251.66K | Jan 13 | View |
| Jan 13, 2021 | Bonnie Anderson | CHAIRMAN AND CEO | 0.00 | $29.23 | -$3.90M | SELL-OPTIONS | 0.00% | 251.66K | Jan 11 - Jan 12 | View |
| Jan 05, 2021 | KEVIN GORDON | DIRECTOR | 0.00 | $28.18 | -$415.90K | SELL-OPTIONS | 0.00% | 0.00 | Jan 04 | View |
| Dec 04, 2020 | Keith Kennedy as Attorney-in-fact | — | -1.09K | $33.98 | -$676.69K | TAX | -1.37% | 78.31K | Dec 02 - Dec 04 | View |
| Nov 13, 2020 | KEVIN GORDON | — | 0.00 | $27.25 | -$397.24K | OPTION EXERCISE | 0.00% | 0.00 | Nov 12 | View |
| Nov 13, 2020 | Mark Ho | — | -13.88K | $45.00 | -$624.38K | SELL | -42.10% | 19.09K | Nov 11 | View |
| Nov 09, 2020 | Walter John Hanna JR | — | 0.00 | $31.83 | -$493.64K | OPTION EXERCISE | 0.00% | 74.31K | Nov 06 | View |
| Nov 06, 2020 | Walter John Hanna JR | — | 0.00 | $24.08 | -$212.75K | OPTION EXERCISE | 0.00% | 74.31K | Nov 05 | View |
| Oct 09, 2020 | Bonnie Anderson | — | 0.00 | $23.43 | -$1.46M | OPTION EXERCISE | 0.00% | 245.23K | Oct 08 | View |
| Oct 07, 2020 | Keith Kennedy as Attorney-in-fact | — | 0.00 | $27.71 | -$37.50K | OPTION EXERCISE | 0.00% | 79.40K | Oct 06 | View |
| Sep 14, 2020 | Bonnie Anderson | — | 0.00 | $19.88 | -$440.66K | OPTION EXERCISE | 0.00% | 245.23K | Sep 10 | View |
| Sep 08, 2020 | Keith Kennedy as Attorney-in-fact | — | -548.00 | $19.38 | -$168.95K | OPTION EXERCISE | -0.69% | 79.40K | Sep 04 | View |
| Sep 01, 2020 | Walter John Hanna JR | — | 0.00 | $20.90 | -$1.41M | OPTION EXERCISE | 0.00% | 74.63K | Aug 31 | View |
| Aug 25, 2020 | Walter John Hanna JR | — | 0.00 | $22.43 | -$38.00K | OPTION EXERCISE | 0.00% | 74.63K | Aug 21 | View |
| Aug 04, 2020 | Walter John Hanna JR | — | 0.00 | $22.49 | -$384.26K | OPTION EXERCISE | 0.00% | 74.63K | Jul 31 | View |
| Aug 04, 2020 | Keith Kennedy as Attorney-in-fact | — | 0.00 | $27.77 | -$302.49K | OPTION EXERCISE | 0.00% | 80.49K | Jul 31 | View |
| Aug 04, 2020 | FA EVAN JONES | — | -40.00K | $35.41 | -$1.42M | SELL | -29.71% | 94.65K | Jul 31 - Aug 03 | View |
| Jul 31, 2020 | Bonnie Anderson | — | 0.00 | $20.55 | -$265.70K | OPTION EXERCISE | 0.00% | 371.29K | Jul 30 | View |
| Jul 27, 2020 | Bonnie Anderson | — | 0.00 | $20.45 | -$76.05K | OPTION EXERCISE | 0.00% | 371.29K | Jul 23 | View |
| Jul 22, 2020 | Walter John Hanna JR | — | 0.00 | $17.23 | -$354.45K | OPTION EXERCISE | 0.00% | 74.52K | Jul 20 - Jul 21 | View |
| Jul 22, 2020 | Bonnie Anderson | — | 0.00 | $20.26 | -$563.01K | OPTION EXERCISE | 0.00% | 371.29K | Jul 20 - Jul 22 | View |
| Jul 16, 2020 | FA EVAN JONES | — | -30.00K | $28.93 | -$868.04K | SELL | -18.22% | 134.65K | Jul 14 - Jul 15 | View |
| Jul 14, 2020 | Keith Kennedy as Attorney-in-fact | — | 0.00 | $21.35 | -$278.10K | OPTION EXERCISE | 0.00% | 80.49K | Jul 13 | View |
| Jul 14, 2020 | ROBERT EPSTEIN | — | 0.00 | $17.50 | -$244.45K | OPTION EXERCISE | 0.00% | 0.00 | Jul 13 | View |
| Jul 07, 2020 | Keith Kennedy | — | -35.97K | $17.89 | -$2.06M | OPTION EXERCISE | -23.11% | 119.63K | Jul 02 - Jul 06 | View |
| Jun 11, 2020 | Bonnie Anderson | — | 0.00 | $15.28 | -$451.26K | OPTION EXERCISE | 0.00% | 371.29K | Jun 10 | View |
| Jun 04, 2020 | Keith Kennedy as attorney-in-fact | — | -1.09K | $16.88 | -$219.60K | TAX | -1.33% | 80.49K | Jun 02 - Jun 03 | View |
| May 19, 2020 | Fred Cohen | — | -40.00K | $26.86 | -$1.07M | SELL | -100.00% | 0.00 | May 18 | View |
| May 13, 2020 | Bonnie Anderson | — | 1.87K | $15.33 | -$453.33K | GRANT OR AWARD | 0.50% | 373.27K | May 11 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.